Sponsored by
They reported great phase 2 trial results - a doubling of the % of recurrent glioblastoma patients alive at the 1 year point, compared to historical controls. They also showed a great dose response curve, which indicates that the treatment effect is real. They are now doing a large phase 3 trial for recurrent gbm. https://virtualtrials.com/Clinical_Trials_Details.cfm?nct=NCT02511405